Key takeaway
In an individual patient data meta-analysis of randomised trials, self-monitoring reduced clinic systolic blood pressure (-3.2 mmHg; 95% CI -4.9 to -1.6) at 12 months, but monitoring alone showed no clear effect (-1.0 mmHg; 95% CI -3.3 to 1.2). Heterogeneity between trials remained large, so effects in any one setting may differ.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Home blood pressure self-monitoring appears to lower blood pressure in hypertension, but it is unclear how it should be delivered and who gains most. The authors pooled patient-level data from trials to estimate its effect on blood pressure and on the proportion of patients controlled below target.
Who and how
Systematic review and individual patient data (IPD) meta-analysis of randomised trials comparing self-monitoring with no self-monitoring in hypertensive patients. Medline, Embase and the Cochrane Library were searched in June 2016. Two reviewers independently assessed eligibility. Of 2,846 articles, 36 trials were eligible and IPD came from 25, including 1 unpublished. Primary outcomes at 12 months were change in mean clinic or ambulatory blood pressure and the proportion controlled below target, with data from 15 of 19 possible studies (7,138 of 8,292 randomised participants, 86%).
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Overall, self-monitoring lowered clinic systolic blood pressure (sBP) versus usual care at 12 months (-3.2 mmHg; 95% CI -4.9 to -1.6).
- 2The effect depended on added support: no clear effect with self-monitoring alone (-1.0 mmHg; 95% CI -3.3 to 1.2), versus a 6.1 mmHg reduction (95% CI -9.0 to -3.2) when combined with intensive support.
- 3It worked best in people on fewer antihypertensive medications and with higher baseline sBP up to 170 mmHg. No differences were seen by sex or by most comorbidities.
- 4In 4 trials (1,478 patients) of self-monitoring with little or no co-intervention, there was no association with lower clinic sBP (-0.2 mmHg; 95% CI -2.2 to 1.8) or ambulatory sBP (1.1 mmHg; 95% CI -0.3 to 2.5). Diastolic results were similar.
Limits & uncertainty
- 1The authors state that significant heterogeneity remained, at least partly from different inclusion criteria, self-monitoring regimes and target blood pressures.
- 2Ambulatory data at 12 months came from only 4 trials, all with little or no co-intervention.
- 3Primary outcome data covered 15 of 19 possible studies, so some trials were missing.
- 4The abstract does not define the content of the intensive support beyond examples such as medication titration, education and lifestyle counselling.
What to take from it
Taking your own readings is unlikely to lower blood pressure by itself; the gain came when readings were used by a clinician, pharmacist or patient to adjust medication, or paired with education or lifestyle counselling. Ask your clinician how your home numbers will be used. Do not change medication on your own.
Reading your own data
A home blood pressure cuff is exactly what this paper concerns. Use the same validated cuff, arm, posture and time of day, take readings consistently, and bring the trend to your clinician instead of reacting to a single value.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Self-monitoring of blood pressure (BP) appears to reduce BP in hypertension but important questions remain regarding effective implementation and which groups may benefit most. This individual patient data (IPD) meta-analysis was performed to better understand the effectiveness of BP self-monitoring to lower BP and control hypertension.
Methods and findings
Medline, Embase, and the Cochrane Library were searched for randomised trials comparing self-monitoring to no self-monitoring in hypertensive patients (June 2016). Two reviewers independently assessed articles for eligibility and the authors of eligible trials were approached requesting IPD. Of 2,846 articles in the initial search, 36 were eligible. IPD were provided from 25 trials, including 1 unpublished study. Data for the primary outcomes-change in mean clinic or ambulatory BP and proportion controlled below target at 12 months-were available from 15/19 possible studies (7,138/8,292 [86%] of randomised participants). Overall, self-monitoring was associated with reduced clinic systolic blood pressure (sBP) compared to usual care at 12 months (-3.2 mmHg, [95% CI -4.9, -1.6 mmHg]). However, this effect was strongly influenced by the intensity of co-intervention ranging from no effect with self-monitoring alone (-1.0 mmHg [-3.3, 1.2]), to a 6.1 mmHg (-9.0, -3.2) reduction when monitoring was combined with intensive support. Self-monitoring was most effective in those with fewer antihypertensive medications and higher baseline sBP up to 170 mmHg. No differences in efficacy were seen by sex or by most comorbidities. Ambulatory BP data at 12 months were available from 4 trials (1,478 patients), which assessed self-monitoring with little or no co-intervention. There was no association between self-monitoring and either lower clinic or ambulatory sBP in this group (clinic -0.2 mmHg [-2.2, 1.8]; ambulatory 1.1 mmHg [-0.3, 2.5]). Results for diastolic blood pressure (dBP) were similar. The main limitation of this work was that significant heterogeneity remained. This was at least in part due to different inclusion criteria, self-monitoring regimes, and target BPs in included studies.
Conclusions
Self-monitoring alone is not associated with lower BP or better control, but in conjunction with co-interventions (including systematic medication titration by doctors, pharmacists, or patients; education; or lifestyle counselling) leads to clinically significant BP reduction which persists for at least 12 months. The implementation of self-monitoring in hypertension should be accompanied by such co-interventions.
Sources & attribution
Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.
Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Earle K, George J, Godwin M, Green BB, Hebert P, Hobbs FDR, Kantola I, Kerry SM, Leiva A, Magid DJ, Mant J, Margolis KL, McKinstry B, McLaughlin MA, Omboni S, Ogedegbe O, Parati G, Qamar N, Tabaei BP, Varis J, Verberk WJ, Wakefield BJ, McManus RJ.
PLoS medicine · 2017-09-19
DOI: 10.1371/journal.pmed.1002389 ↗PubMed · 28926573 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

